Part VIIIB Specials Drug Tariff – August 2019 Update

Rokshaw Laboratories can announce the following changes and provide an analysis for the Part VIIIB Specials Drug Tariff, with effect of August 1st 2019.

The following changes are:

  • 3 Products Added
  • 3 Products Removed
  • 212 Price Decreases
  • 37 Price Increases

In summary, the August 2019 Specials Drug Tariff has shown the biggest decrease in the overall average sales price in years (now at £72.51, down from £80.07) with the popular product decreases being Ketamine Solution, Spironolactone Suspension and Chloral Hydrate Solution. These significant decreases are continuing to provide excellent value for the NHS moving into the new quarter and the foreseeable future.  We predict that the trend will continue with prices getting even lower in the upcoming updates, despite seeing the overall average sales price reaching a record low.

Rokshaw Laboratories also predicts that despite 3 product additions in the August update, the upcoming November 2019 and February 2020 updates will see the addition of a lot more lines to ensure that prices are appropriately moderated across the Specials industry.


What can Rokshaw Laboratories Do?


Despite these changes, Rokshaw Laboratories will always be able to provide your pharmacy with a competitive price on Drug Tariff that allows for an ethical earning opportunity for community pharmacy and value for the NHS.

If you wish to speak with us to see what we can do you on Drug Tariff lines going forward, then please find our contact details here or fill out our Online Enquiry Form. We also provide a wide variety of Non Tariff Specials and Special Obtains that you can ask us about at any time as part of our overall “One Stop Shop” Specials Service.

If you wish to work out your exact reimbursements on Drug Tariff lines, you can use our Drug Tariff Calculator, which has been updated from the 1st August 2019. For more information on the entire August 2019 Specials Drug Tariff, please access the following link for the full Drug Tariff.